作者
Guillaume Ploussard, Jonathan I Epstein, Rodolfo Montironi, Peter R Carroll, Manfred Wirth, Marc-Oliver Grimm, Anders S Bjartell, Francesco Montorsi, Stephen J Freedland, Andreas Erbersdobler, Theodorus H Van Der Kwast
发表日期
2011/8/1
来源
European urology
卷号
60
期号
2
页码范围
291-303
出版商
Elsevier
简介
Context
The notion of insignificant prostate cancer (Ins-PCa) has progressively emerged in the past two decades. The clinical relevance of such a definition was based on the fact that low-grade, small-volume, and organ-confined prostate cancer (PCa) may be indolent and unlikely to progress to biologic significance in the absence of treatment.
Objective
To review the definition of Ins-PCa, its incidence, and the clinical impact of Ins-PCa on the contemporary management of PCa.
Evidence acquisition
A review of the literature was performed using the Medline, Scopus, and Web of Science databases with no restriction on language up to September 2010. The literature search used the following terms: insignificant, indolent, minute, microfocal, minimal, low volume, low risk, and prostate cancer.
Evidence synthesis
The most commonly used criteria to define Ins-PCa are based on the pathologic assessment of the radical …
引用总数
2011201220132014201520162017201820192020202120222023202442127373641572824311218147
学术搜索中的文章